|
Volumn 38, Issue 2, 2002, Pages 166-169
|
Allogeneic bone marrow transplant improves outcome for juvenile myelomonocytic leukaemia
|
Author keywords
Allogeneic bone marrow transplant; Child; Juvenile myelomonocytic leukaemia; Survival; Treatment
|
Indexed keywords
ANTILEUKEMIC AGENT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC PROCEDURE;
FEMALE;
FOLLOW UP;
HEPATOSPLENOMEGALY;
HUMAN;
INFANT;
LYMPHADENOPATHY;
MEDICAL RECORD;
MULTICENTER STUDY;
MYELOMONOCYTIC LEUKEMIA;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
REMISSION;
SCHOOL CHILD;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BONE MARROW TRANSPLANTATION;
FEMALE;
HOSPITALS, PEDIATRIC;
HUMANS;
INFANT;
LEUKEMIA, MYELOMONOCYTIC, ACUTE;
MALE;
NEW SOUTH WALES;
REMISSION INDUCTION;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 0036268208
PISSN: 10344810
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1754.2002.00764.x Document Type: Article |
Times cited : (15)
|
References (11)
|